港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

銀諾醫藥-B

3.275

+0.0752.34%

成交量：216.06萬

成交額：696.99萬

市值：14.97億

市盈率：-4.15

高：3.295

開：3.220

低：3.130

收：3.200

52周最高：48.360

52周最低：3.130

股本：4.57億

香港流通股本：4.20億

量比：0.39

換手率：0.51%

股息：- -

股息率：- -

每股收益(LYR):-0.790

淨資產收益率：-41.16%

總資產收益率：-19.04%

市淨率：1.35

市盈率(LYR):-4.15

市銷率: 8.30

資料載入中...

總覽公司新聞資訊公告

銀諾醫藥-B：Cowin Capital Investment III Limited減持，好倉比例降至3.43%

銀諾醫藥-B：Cowin Capital Investment Limited減持，好倉比例降至3.43%

銀諾醫藥-B：Cowin China Growth Fund II, L.P.減持，好倉比例降至3.43%

銀諾醫藥-B(02591)：創始人及多名高級管理層作出自願禁售承諾

銀諾醫藥-B（02591）高管自願再鎖定股份6個月

廣州銀諾醫藥集團創始人及高管承諾自2026年8月15日起六個月股份鎖定期

Cowin China Growth Fund II, L.P.減持銀諾醫藥-B(02591.HK)287萬股每股作價約3.64港元

銀諾醫藥-B：Cowin Capital Investment III Limited減持，好倉比例降至4.23%

銀諾醫藥-B：Cowin China Growth Fund II, L.P.減持，好倉比例降至4.23%

銀諾醫藥-B：Cowin Capital Investment II LTD減持，好倉比例降至4.23%

銀諾醫藥-B：Cowin Capital Investment Limited減持，好倉比例降至4.23%

銀諾醫藥-B：鄭偉鶴減持，好倉比例降至6.95%

銀諾醫藥-B：黃荔減持，好倉比例降至6.95%

銀諾醫藥8月月報：股本維持不變

銀諾醫藥-B：鄭偉鶴減持，好倉比例降至7.84%

銀諾醫藥-B：Cowin Capital Investment III Limited減持，好倉比例降至4.91%

銀諾醫藥-B：黃荔減持，好倉比例降至7.84%

銀諾醫藥-B：Cowin Capital Investment II LTD減持，好倉比例降至4.91%

銀諾醫藥-B：Cowin Capital Investment Limited減持，好倉比例降至4.91%

銀諾醫藥-B：Cowin China Growth Fund II, L.P.減持，好倉比例降至4.91%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/02591/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"銀諾醫藥-B","latestPrice":3.275,"timestamp":1792742889003,"preClose":3.2,"halted":0,"volume":2160600,"delay":0,"changeRate":0.023437499999999917,"floatShares":420285370,"shares":457000000,"eps":-0.79,"marketStatus":"休市中","change":0.075,"latestTime":"10-23 16:08:09","open":3.22,"high":3.295,"low":3.13,"amount":6969871,"amplitude":0.051563,"askPrice":3.275,"askSize":3000,"bidPrice":3.26,"bidSize":6800,"shortable":3,"etf":0,"ttmEps":-0.853301,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":7,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":3.2,"openAndCloseTimeList":[[1792719000000,1792728000000],[1792731600000,1792742400000]],"volumeRatio":0.391407370896323,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-19.04%","roe":"-41.16%","lyrEps":-0.79,"volumeRatio":0.391407370896323,"shares":457000000,"dividePrice":0,"high":3.295,"amplitude":0.051563,"preClose":3.2,"low":3.13,"week52Low":3.13,"pbRate":"1.35","psRate":"8.30","week52High":48.36,"institutionHeld":0,"latestPrice":3.275,"committee":0.387755,"eps":-0.79,"divideRate":0,"volume":2160600,"delay":0,"ttmEps":-0.853301,"open":3.22,"prevYearClose":30.64,"prevWeekClose":3.645,"prevMonthClose":3.85,"prevQuarterClose":3.85,"fiveDayClose":3.645,"twentyDayClose":4.125,"sixtyDayClose":7.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02591","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775750400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2026-10-15","current":-3.838036,"percent":0.968531,"low":-137.156472,"twenty":-64.894515,"median":-40.291124,"eighty":-10.379801,"high":-4.018047,"avg":-40.249758,"sd":31.205124,"marketCap":1665106527},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209},{"date":"2025-09-12","current":-83.843855,"twenty":-126.417438,"median":-105.433356,"eighty":-83.374192,"marketCap":20355870191},{"date":"2025-09-19","current":-79.271387,"twenty":-126.095992,"median":-93.890147,"eighty":-81.90749,"marketCap":19232094592},{"date":"2025-09-26","current":-78.986763,"twenty":-125.916102,"median":-85.498552,"eighty":-79.429082,"marketCap":19113321562},{"date":"2025-10-03","current":-76.5387,"twenty":-122.116665,"median":-83.843855,"eighty":-78.76383,"marketCap":18565138343},{"date":"2025-10-10","current":-69.068341,"twenty":-116.871032,"median":-83.374192,"eighty":-77.810518,"marketCap":16728724560},{"date":"2025-10-17","current":-67.838616,"twenty":-109.436934,"median":-79.738352,"eighty":-74.826182,"marketCap":16418087403},{"date":"2025-10-24","current":-59.813644,"twenty":-105.816054,"median":-79.429082,"eighty":-68.576451,"marketCap":14481173363},{"date":"2025-10-31","current":-57.61442,"twenty":-103.460611,"median":-78.986763,"eighty":-66.346017,"marketCap":13969535692},{"date":"2025-11-07","current":-56.556997,"twenty":-100.097405,"median":-78.243448,"eighty":-63.14919,"marketCap":13704580470},{"date":"2025-11-14","current":-61.96171,"twenty":-95.010372,"median":-77.299283,"eighty":-61.326336,"marketCap":15056765743},{"date":"2025-11-21","current":-54.467459,"twenty":-87.179427,"median":-75.823033,"eighty":-60.1184,"marketCap":13229488347},{"date":"2025-11-28","current":-82.342484,"twenty":-85.508442,"median":-76.5387,"eighty":-60.703449,"marketCap":20072642195},{"date":"2025-12-05","current":-82.313405,"twenty":-85.248884,"median":-75.823033,"eighty":-61.326336,"marketCap":20100051356},{"date":"2025-12-12","current":-63.824496,"twenty":-84.462171,"median":-74.404407,"eighty":-61.326336,"marketCap":15614085348},{"date":"2025-12-19","current":-62.072323,"twenty":-83.725798,"median":-74.049705,"eighty":-60.286674,"marketCap":15221220708},{"date":"2025-12-24","current":-59.762449,"twenty":-83.548712,"median":-73.276127,"eighty":-59.816947,"marketCap":14700446650},{"date":"2026-01-02","current":-56.27243,"twenty":-83.409096,"median":-71.366231,"eighty":-59.572219,"marketCap":13896444596},{"date":"2026-01-09","current":-57.1291,"twenty":-82.548826,"median":-69.803372,"eighty":-58.239982,"marketCap":14143127045},{"date":"2026-01-16","current":-56.980838,"twenty":-82.319221,"median":-67.499105,"eighty":-57.682607,"marketCap":14152263432},{"date":"2026-01-23","current":-58.213825,"twenty":-82.096799,"median":-66.291021,"eighty":-57.601428,"marketCap":14444627815},{"date":"2026-01-30","current":-54.613459,"twenty":-81.934522,"median":-64.906051,"eighty":-57.510573,"marketCap":13613216600},{"date":"2026-02-06","current":-49.064319,"twenty":-80.235292,"median":-63.834,"eighty":-57.242442,"marketCap":12261031327},{"date":"2026-02-13","current":-50.165477,"twenty":-79.691019,"median":-62.941647,"eighty":-57.039695,"marketCap":12608214032},{"date":"2026-02-20","current":-50.419859,"twenty":-79.623791,"median":-62.643943,"eighty":-56.891323,"marketCap":12653895967},{"date":"2026-02-27","current":-50.052949,"twenty":-79.470699,"median":-62.017016,"eighty":-56.651056,"marketCap":12699577902},{"date":"2026-03-06","current":-43.88908,"twenty":-79.397543,"median":-60.902753,"eighty":-56.29247,"marketCap":11045891858},{"date":"2026-03-13","current":-39.965904,"twenty":-79.214462,"median":-60.292057,"eighty":-54.71959,"marketCap":10104843999},{"date":"2026-03-20","current":-39.174717,"twenty":-78.964109,"median":-59.813644,"eighty":-50.865048,"marketCap":9867297938},{"date":"2026-03-27","current":-24.701097,"twenty":-78.775514,"median":-59.491697,"eighty":-50.290678,"marketCap":9547524394},{"date":"2026-04-02","current":-24.535908,"twenty":-78.383597,"median":-58.823921,"eighty":-50.052949,"marketCap":9529251620},{"date":"2026-04-10","current":-24.978414,"twenty":-78.348547,"median":-58.584467,"eighty":-49.631191,"marketCap":9775934068},{"date":"2026-04-17","current":-23.474521,"twenty":-78.227102,"median":-58.112982,"eighty":-48.421657,"marketCap":9191205301},{"date":"2026-04-24","current":-19.658213,"twenty":-78.155492,"median":-57.844151,"eighty":-44.116877,"marketCap":7697406030},{"date":"2026-04-30","current":-16.329046,"twenty":-77.825679,"median":-57.660489,"eighty":-41.074266,"marketCap":6395470886},{"date":"2026-05-08","current":-17.822364,"twenty":-77.322024,"median":-57.626503,"eighty":-40.478309,"marketCap":5778764764},{"date":"2026-05-15","current":-17.368107,"twenty":-77.157551,"median":-57.517602,"eighty":-40.012158,"marketCap":5646287153},{"date":"2026-05-22","current":-17.112125,"twenty":-76.782452,"median":-57.446424,"eighty":-25.37304,"marketCap":5550355090},{"date":"2026-05-29","current":-15.607197,"twenty":-76.252433,"median":-57.23775,"eighty":-24.916387,"marketCap":5079831160},{"date":"2026-06-05","current":-14.014909,"twenty":-75.020932,"median":-57.073515,"eighty":-24.414835,"marketCap":4568193490},{"date":"2026-06-12","current":-11.752443,"twenty":-74.621039,"median":-56.924891,"eighty":-23.900197,"marketCap":3828146144},{"date":"2026-06-18","current":-10.549084,"twenty":-74.404407,"median":-56.73827,"eighty":-23.474521,"marketCap":3444417891},{"date":"2026-06-26","current":-9.60263,"twenty":-74.160764,"median":-56.642046,"eighty":-20.865982,"marketCap":3120076153},{"date":"2026-07-03","current":-11.351574,"twenty":-74.088566,"median":-56.533624,"eighty":-19.581214,"marketCap":3691100339},{"date":"2026-07-10","current":-11.238926,"twenty":-74.037218,"median":-56.208644,"eighty":-19.055481,"marketCap":3649986598},{"date":"2026-07-17","current":-10.540302,"twenty":-73.42668,"median":-55.144116,"eighty":-17.753872,"marketCap":3435281504},{"date":"2026-07-24","current":-10.636027,"twenty":-71.947117,"median":-53.621015,"eighty":-17.028947,"marketCap":3467258858},{"date":"2026-07-31","current":-10.1543,"twenty":-71.465685,"median":-51.153424,"eighty":-16.590446,"marketCap":3316508473},{"date":"2026-08-07","current":-10.609247,"twenty":-70.999854,"median":-50.412223,"eighty":-15.817726,"marketCap":3471827052},{"date":"2026-08-14","current":-9.215586,"twenty":-70.625283,"median":-50.222782,"eighty":-14.020929,"marketCap":3019575896},{"date":"2026-08-21","current":-5.675745,"twenty":-69.656366,"median":-50.052949,"eighty":-12.083492,"marketCap":1863822943},{"date":"2026-08-28","current":-4.445704,"twenty":-68.330506,"median":-49.617462,"eighty":-11.852702,"marketCap":1733629429},{"date":"2026-09-04","current":-4.209722,"twenty":-67.634909,"median":-49.247121,"eighty":-11.642751,"marketCap":1642265559},{"date":"2026-09-11","current":-4.665967,"twenty":-67.023292,"median":-47.343126,"eighty":-11.381044,"marketCap":1822709202},{"date":"2026-09-18","current":-4.496374,"twenty":-66.568075,"median":-44.268741,"eighty":-11.284155,"marketCap":1758754493},{"date":"2026-09-25","current":-4.522512,"twenty":-66.254011,"median":-42.078385,"eighty":-11.102429,"marketCap":1765606783},{"date":"2026-10-02","current":-4.359948,"twenty":-65.694759,"median":-40.875046,"eighty":-10.830949,"marketCap":1703936171},{"date":"2026-10-09","current":-4.202749,"twenty":-65.009184,"median":-40.498003,"eighty":-10.543815,"marketCap":1644549656},{"date":"2026-10-15","current":-4.247779,"twenty":-64.894515,"median":-40.291124,"eighty":-10.379801,"marketCap":1665106527}],"updateTime":1792849697067},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197227945","title":"銀諾醫藥-B：Cowin Capital Investment III Limited減持，好倉比例降至3.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1197227945","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197227945?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:33","pubTimestamp":1788860036,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment III Limited于2026年9月8日以每股均价3.6117港元卖出银诺医药-B股份337.00万股，涉资约1217.14万港元。Cowin Capital Investment III Limited此次减持前持有银诺医药-B好仓1778.64万股，占比4.23%；减持后持股量为1441.64万股，好仓比例降至3.43%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129685377","title":"銀諾醫藥-B：Cowin Capital Investment Limited減持，好倉比例降至3.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129685377","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129685377?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:33","pubTimestamp":1788860023,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment Limited于2026年9月8日以每股均价3.6117港元卖出银诺医药-B股份337.00万股，涉资约1217.14万港元。Cowin Capital Investment Limited此次减持前持有银诺医药-B好仓1778.64万股，占比4.23%；减持后持股量为1441.64万股，好仓比例降至3.43%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128355022","title":"銀諾醫藥-B：Cowin China Growth Fund II, L.P.減持，好倉比例降至3.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128355022","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128355022?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:24","pubTimestamp":1788859488,"startTime":"0","endTime":"0","summary":"于2026年9月8日，Cowin China Growth Fund II, L.P.以每股均价3.6117港元卖出银诺医药-B股份337.00万股，涉资约1217.14万港元。Cowin China Growth Fund II, L.P.此次减持前持有银诺医药-B好仓1778.64万股，占比4.23%；减持后持股量为1441.64万股，好仓比例降至3.43%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665182313","title":"銀諾醫藥-B(02591)：創始人及多名高級管理層作出自願禁售承諾","url":"https://stock-news.laohu8.com/highlight/detail?id=2665182313","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665182313?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 17:26","pubTimestamp":1788773218,"startTime":"0","endTime":"0","summary":"智通财经APP讯，银诺医药-B(02591)发布公告，本公司董事会已获本集团创始人、本公司董事长、执行董事、总经理兼本公司主要股东WANG QINGHUA博士(Wang博士);执行董事、香港医韵医药技术有限公司股东兼本公司雇员激励平台广州诺帕企业管理合伙企业(有限合伙)(广州诺帕)的有限合伙人姜帆女士(姜女士);执行董事兼广州诺帕的有限合伙人徐文洁女士(徐女士);及执行董事兼广州诺帕的有限合伙人黄","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160134448","title":"銀諾醫藥-B（02591）高管自願再鎖定股份6個月","url":"https://stock-news.laohu8.com/highlight/detail?id=1160134448","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160134448?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 17:25","pubTimestamp":1788773150,"startTime":"0","endTime":"0","summary":"2026年9月7日，广州银诺医药集团股份有限公司宣布，公司创始人及多名高级管理层自愿延长禁售期六个月。上述人员已分别承诺，自2026年8月15日起，连续六个月内不出售其所直接或间接持有的任何银诺医药-B股份或相关权益。公司表示，相关承诺反映管理层对公司未来前景及长期发展的信心。公司提醒投资者及股东在买卖公司证券时保持审慎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130976354","title":"廣州銀諾醫藥集團創始人及高管承諾自2026年8月15日起六個月股份鎖定期","url":"https://stock-news.laohu8.com/highlight/detail?id=1130976354","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130976354?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 17:25","pubTimestamp":1788773109,"startTime":"0","endTime":"0","summary":"广州银诺医药集团股份有限公司（Innogen Pharmaceutical Group Co.）宣布，公司创始人及高级管理层已承诺自2026年8月15日起实施为期六个月的股份锁定期。此举彰显了核心团队对公司长期发展前景的坚定信心，同时也有助于稳定市场预期，传递出积极的治理信号。锁定期安排从8月中旬正式启动，届时相关方将在此期间不转让或处置所持股份，以进一步维护股东利益并支持公司战略稳步推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664933930","title":"Cowin China Growth Fund II, L.P.減持銀諾醫藥-B(02591.HK)287萬股 每股作價約3.64港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664933930","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664933930?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 19:19","pubTimestamp":1788520744,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160865595","title":"銀諾醫藥-B：Cowin Capital Investment III Limited減持，好倉比例降至4.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160865595","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160865595?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 17:51","pubTimestamp":1788515507,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment III Limited于2026年9月3日以每股均价3.6397港元卖出银诺医药-B股份287.00万股，涉资约1044.59万港元。Cowin Capital Investment III Limited此次减持前持有银诺医药-B好仓2065.64万股，占比4.91%；减持后持股量为1778.64万股，好仓比例降至4.23%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119293795","title":"銀諾醫藥-B：Cowin China Growth Fund II, L.P.減持，好倉比例降至4.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119293795","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119293795?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 17:33","pubTimestamp":1788514406,"startTime":"0","endTime":"0","summary":"Cowin China Growth Fund II, L.P.于2026年9月3日以每股均价3.6397港元卖出银诺医药-B股份287.00万股，涉资约1044.59万港元。Cowin China Growth Fund II, L.P.此次减持前持有银诺医药-B好仓2065.64万股，占比4.91%；减持后持股量为1778.64万股，好仓比例降至4.23%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165427375","title":"銀諾醫藥-B：Cowin Capital Investment II LTD減持，好倉比例降至4.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165427375","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165427375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 17:20","pubTimestamp":1788513645,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment II LTD于2026年9月3日以每股均价3.6397港元卖出银诺医药-B股份287.00万股，涉资约1044.59万港元。Cowin Capital Investment II LTD此次减持前持有银诺医药-B好仓2065.64万股，占比4.91%；减持后持股量为1778.64万股，好仓比例降至4.23%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110548895","title":"銀諾醫藥-B：Cowin Capital Investment Limited減持，好倉比例降至4.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110548895","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110548895?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 17:18","pubTimestamp":1788513481,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment Limited于2026年9月3日以每股均价3.6397港元卖出银诺医药-B股份287.00万股，涉资约1044.59万港元。Cowin Capital Investment Limited此次减持前持有银诺医药-B好仓2065.64万股，占比4.91%；减持后持股量为1778.64万股，好仓比例降至4.23%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157478808","title":"銀諾醫藥-B：鄭偉鶴減持，好倉比例降至6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157478808","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157478808?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 17:16","pubTimestamp":1788513409,"startTime":"0","endTime":"0","summary":"郑伟鹤于2026年9月3日以每股均价3.6394港元卖出银诺医药-B股份375.00万股，涉资约1364.78万港元。郑伟鹤此次减持前持有银诺医药-B好仓3294.11万股，占比7.84%；减持后持股量为2919.11万股，好仓比例降至6.95%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125845401","title":"銀諾醫藥-B：黃荔減持，好倉比例降至6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125845401","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125845401?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:32","pubTimestamp":1788427959,"startTime":"0","endTime":"0","summary":"黄荔于2026年9月3日以每股均价3.6394港元卖出银诺医药-B（02591）股份375.00万股，涉资约1364.78万港元。黄荔此次减持前持有银诺医药-B好仓3294.11万股，占比7.84%；减持后持股量为2919.11万股，好仓比例降至6.95%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165755167","title":"銀諾醫藥8月月報：股本維持不變","url":"https://stock-news.laohu8.com/highlight/detail?id=1165755167","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165755167?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:01","pubTimestamp":1788426076,"startTime":"0","endTime":"0","summary":"银诺医药-B于2026年9月3日发布2026年8月股份变动月报表。公告显示，截至2026年8月31日，公司法定/注册股本为人民币456,819,349元，均为每股面值人民币1元的普通股。其中，已于香港联交所上市的H股为420,285,370股，非上市股份为36,533,979股。报告期内，公司上述注册股本及已发行股份数量均保持不变，无新增发行、购回、注销或以库藏形式持有的股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107526269","title":"銀諾醫藥-B：鄭偉鶴減持，好倉比例降至7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107526269","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107526269?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 17:41","pubTimestamp":1787910098,"startTime":"0","endTime":"0","summary":"郑伟鹤于2026年8月27日以每股均价3.9967港元卖出银诺医药-B股份455.00万股，涉资约1818.50万港元。郑伟鹤此次减持前持有银诺医药-B好仓3749.11万股，占比8.92%；减持后持股量为3294.11万股，好仓比例降至7.84%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119528306","title":"銀諾醫藥-B：Cowin Capital Investment III Limited減持，好倉比例降至4.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119528306","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119528306?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 17:32","pubTimestamp":1787909561,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment III Limited于2026年8月27日以每股均价3.9975港元卖出银诺医药-B股份350.00万股，涉资约1399.12万港元。Cowin Capital Investment III Limited此次减持前持有银诺医药-B好仓2415.64万股，占比5.75%；减持后持股量为2065.64万股，好仓比例降至4.91%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177222002","title":"銀諾醫藥-B：黃荔減持，好倉比例降至7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177222002","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177222002?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 17:22","pubTimestamp":1787908976,"startTime":"0","endTime":"0","summary":"黄荔于2026年8月27日以每股均价3.9967港元卖出银诺医药-B股份455.00万股，涉资约1818.50万港元。黄荔此次减持前持有银诺医药-B好仓3749.11万股，占比8.92%；减持后持股量为3294.11万股，好仓比例降至7.84%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184231860","title":"銀諾醫藥-B：Cowin Capital Investment II LTD減持，好倉比例降至4.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184231860","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184231860?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 17:22","pubTimestamp":1787908972,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment II LTD于2026年8月27日以每股均价3.9975港元卖出银诺医药-B股份350.00万股，涉资约1399.12万港元。Cowin Capital Investment II LTD此次减持前持有银诺医药-B好仓2415.64万股，占比5.75%；减持后持股量为2065.64万股，好仓比例降至4.91%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174539144","title":"銀諾醫藥-B：Cowin Capital Investment Limited減持，好倉比例降至4.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174539144","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174539144?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 17:22","pubTimestamp":1787908968,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment Limited于2026年8月27日以每股均价3.9975港元卖出银诺医药-B股份350.00万股，涉资约1399.12万港元。Cowin Capital Investment Limited此次减持前持有银诺医药-B好仓2415.64万股，占比5.75%；减持后持股量为2065.64万股，好仓比例降至4.91%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138273560","title":"銀諾醫藥-B：Cowin China Growth Fund II, L.P.減持，好倉比例降至4.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138273560","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138273560?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 17:22","pubTimestamp":1787908956,"startTime":"0","endTime":"0","summary":"Cowin China Growth Fund II, L.P.于2026年8月27日以每股均价3.9975港元卖出银诺医药-B股份350.00万股，涉资约1399.12万港元。Cowin China Growth Fund II, L.P.此次减持前持有银诺医药-B好仓2415.64万股，占比5.75%；减持后持股量为2065.64万股，好仓比例降至4.91%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":123,"code":"91000000","status":"200"}]}}